Overall, these findings provide novel evidence for the association of perceived maternal anxiety and depression during pregnancy and the dysregulation of placental gene expression of CRH, AVP, and HSD11B2 as potential mechanisms underlying adverse physiological and neurodevelopmental consequences for the newborn ultimately contributing to disease risk. The gene discussed is AVP; the disease is depressive disorder.